KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Non-Current Deffered Revenue (2017 - 2019)

Guardant Health (GH) has disclosed Non-Current Deffered Revenue for 3 consecutive years, with $10.6 million as the latest value for Q3 2019.

  • Quarterly Non-Current Deffered Revenue rose 38.58% to $10.6 million in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $10.6 million through Sep 2019, up 38.58% year-over-year, with the annual reading at $7.8 million for FY2018, 19.99% up from the prior year.
  • Non-Current Deffered Revenue hit $10.6 million in Q3 2019 for Guardant Health, down from $10.9 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $10.9 million in Q2 2019 to a low of $6.5 million in Q4 2017.
  • Historically, Non-Current Deffered Revenue has averaged $8.7 million across 3 years, with a median of $8.4 million in 2018.
  • Biggest five-year swings in Non-Current Deffered Revenue: increased 19.99% in 2018 and later skyrocketed 38.58% in 2019.
  • Year by year, Non-Current Deffered Revenue stood at $6.5 million in 2017, then rose by 19.99% to $7.8 million in 2018, then skyrocketed by 34.68% to $10.6 million in 2019.
  • Business Quant data shows Non-Current Deffered Revenue for GH at $10.6 million in Q3 2019, $10.9 million in Q2 2019, and $9.0 million in Q1 2019.